David Boettiger, PhD

TitlePostdoctoral Scholar
InstitutionUniversity of California San Francisco
DepartmentInstitute for Health Policy Studies
Address3333 California Street
San Francisco CA 94118
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of New South Wales, AustraliaPhD2015
    University of Utrecht, NetherlandsMSc2011Epidemiology
    University of Newcastle, AustraliaMSc2005Pharmacy
    University of Newcastle, AustraliaBA2003Biomedical Science
    Collapse Awards and Honors
    UCSF & UNSW Sydney2018  - 2021NHMRC Early Career Fellowship
    UNSW Sydney2016  - 2016Gilead Fellowship

    Collapse Overview 
    Collapse Overview
    Dr Boettiger is a UCSF research fellow with a co-appointment at the Kirby Institute in Sydney, Australia. He is primarily interested in optimising the care of people living with HIV and other infectious diseases. Dr Boettiger's current research is evaluating the cost-effectiveness of non-communicable disease prevention in people living with HIV in the US and Brazil. Prior to this, he worked with the US CDC providing epidemiological expertise for local, provincial and national HIV and TB surveillance activities in Vietnam, and was lead biostatistician for the TREAT Asia HIV Observational Database (TAHOD). Dr Boettiger's research has attracted both government and pharma funding, and he has successfully collaborated with the WHO on a range of global HIV and hepatitis projects. For example, part of his work on TAHOD led to the WHOs recommendation to reduce CD4 count testing in patients with suppressed HIV which resulted in substantial cost savings among implementing countries. Dr Boettiger encourages anyone with similar research interests to get in touch with him.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Boettiger DC, Law MG, Dore GJ, Guy R, Callander D, Donovan B, O'Connor CC, Fairley CK, Hellard M, Matthews G. Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance data. BMC Infect Dis. 2017 12 01; 17(1):740. PMID: 29191154.
      View in: PubMed
    2. Jung IY, Boettiger D, Wong WW, Lee MP, Kiertiburanakul S, Chaiwarith R, Avihingsanon A, Tanuma J, Kumarasamy N, Kamarulzaman A, Zhang F, Kantipong P, Ng OT, Sim BLH, Law M, Ross J, Choi JY. The treatment outcomes of antiretroviral substitutions in routine clinical settings in Asia; data from the TREAT Asia HIV Observational Database (TAHOD). J Int AIDS Soc. 2017 Dec; 20(4). PMID: 29243388.
      View in: PubMed
    3. Kosalaraksa P, Boettiger DC, Bunupuradah T, Hansudewechakul R, Saramony S, Do VC, Sudjaritruk T, Yusoff NKN, Razali KAM, Nguyen LV, Nallusamy R, Fong SM, Kurniati N, Truong KH, Sohn AH, Chokephaibulkit K. Low Risk of CD4 Decline After Immune Recovery in Human Immunodeficiency Virus-Infected Children With Viral Suppression. J Pediatric Infect Dis Soc. 2017 Jun 01; 6(2):173-177. PMID: 27295973.
      View in: PubMed
    4. Kiertiburanakul S, Boettiger D, Ng OT, Van Kinh N, Merati TP, Avihingsanon A, Wong WW, Lee MP, Chaiwarith R, Kamarulzaman A, Kantipong P, Zhang F, Choi JY, Kumarasamy N, Ditangco R, Cuong DD, Oka S, Sim BLH, Ratanasuwan W, Ly PS, Yunihastuti E, Pujari S, Ross JL, Law M, Sungkanuparph S. Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings. AIDS Res Ther. 2017; 14:27. PMID: 28484509.
      View in: PubMed
    5. Sudjaritruk T, Aurpibul L, Ly PS, Le TPK, Bunupuradah T, Hansudewechakul R, Lumbiganon P, Chokephaibulkit K, Nik Yusoff NK, Nguyen LV, Mohd Razali KA, Fong MS, Nallusamy RA, Kurniati N, Do VC, Boettiger DC, Sohn AH, Kariminia A. Incidence of Postsuppression Virologic Rebound in Perinatally HIV-Infected Asian Adolescents on Stable Combination Antiretroviral Therapy. J Adolesc Health. 2017 Jul; 61(1):91-98. PMID: 28343759.
      View in: PubMed
    6. Wijayanti A, Zhao CY, Boettiger D, Chiang YZ, Ishii N, Hashimoto T, Murrell DF. The Reliability, Validity and Responsiveness of Two Disease Scores (BPDAI and ABSIS) for Bullous Pemphigoid: Which One to Use? Acta Derm Venereol. 2017 01 04; 97(1):24-31. PMID: 27244117.
      View in: PubMed
    7. Durier N, Yunihastuti E, Ruxrungtham K, Kinh NV, Kamarulzaman A, Boettiger D, Widhani A, Avihingsanon A, Huy BV, Syed Omar SF, Sanityoso A, Chittmittrapap S, Dung NT, Pillai V, Suwan-Ampai T, Law M, Sohn AH, Matthews G. Chronic hepatitis C infection and liver disease in HIV-coinfected patients in Asia. J Viral Hepat. 2017 Mar; 24(3):187-196. PMID: 27917597.
      View in: PubMed
    8. Ahn JY, Boettiger D, Kiertiburanakul S, Merati TP, Huy BV, Wong WW, Ditangco R, Lee MP, Oka S, Durier N, Choi JY. Incidence of syphilis seroconversion among HIV-infected persons in Asia: results from the TREAT Asia HIV Observational Database. J Int AIDS Soc. 2016; 19(1):20965. PMID: 27774955.
      View in: PubMed
    9. Do TC, Boettiger D, Law M, Pujari S, Zhang F, Chaiwarith R, Kiertiburanakul S, Lee MP, Ditangco R, Wong WW, Nguyen KV, Merati TP, Pham TT, Kamarulzaman A, Oka S, Yunihastuti E, Kumarasamy N, Kantipong P, Choi JY, Ng OT, Durier N, Ruxrungtham K. Smoking and projected cardiovascular risk in an HIV-positive Asian regional cohort. HIV Med. 2016 08; 17(7):542-9. PMID: 27430354.
      View in: PubMed
    10. Boettiger DC, Muktiarti D, Kurniati N, Truong KH, Saghayam S, Ly PS, Hansudewechakul R, Van Nguyen L, Do VC, Sudjaritruk T, Lumbiganon P, Chokephaibulkit K, Bunupuradah T, Nik Yusoff NK, Wati DK, Mohd Razali KA, Fong MS, Nallusamy RA, Sohn AH, Kariminia A. Early Height and Weight Changes in Children Using Cotrimoxazole Prophylaxis With Antiretroviral Therapy. Clin Infect Dis. 2016 Nov 01; 63(9):1236-1244. PMID: 27470239.
      View in: PubMed
    11. Boettiger DC, Sabin CA, Grulich A, Ryom L, Bonnet F, Reiss P, Monforte Ad, Kirk O, Phillips A, Bower M, Fätkenheuer G, Lundgren JD, Law M. Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals? AIDS. 2016 Jun 19; 30(10):1629-37. PMID: 26854812; PMCID: PMC4889546 [Available on 06/19/17].
    12. Lumbiganon P, Kosalaraksa P, Bunupuradah T, Boettiger D, Saphonn V, Truong KH, Kurniati N, Hansudewechakul R, Do VC, Sudjaritruk T, Kumarasamy N, Kongstan N, Yusoff NK, Nguyen LV, Wati DK, Razali K, Sohn AH, Kariminia A. HIV-infected children in the Asia-Pacific region with baseline severe anemia: antiretroviral therapy and outcomes. Asian Biomed (Res Rev News). 2016 Jun; 10(3):229-234. PMID: 28239430.
      View in: PubMed
    13. A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort. AIDS Res Hum Retroviruses. 2016 08; 32(8):772-81. PMID: 27030657.
      View in: PubMed
    14. Boettiger DC, Aurpibul L, Hudaya DM, Fong SM, Lumbiganon P, Saphonn V, Truong KH, Hansudewechakul R, Nguyen LV, Do VC, Bunupuradah T, Chokephaibulkit K, Nik Yusoff NK, Kumarasamy N, Wati DK, Razali KA, Kariminia A. Antiretroviral Therapy in Severely Malnourished, HIV-infected Children in Asia. Pediatr Infect Dis J. 2016 May; 35(5):e144-51. PMID: 26835972; PMCID: PMC4829479 [Available on 05/01/17].
    15. Boettiger DC, Khol V, Durier N, Law M, Sun LP. HIV viral suppression in TREAT Asia HIV Observational Database enrolled adults on antiretroviral therapy at the Social Health Clinic, the National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia. Antivir Ther. 2016; 21(8):725-730. PMID: 27124891.
      View in: PubMed
    16. Boettiger DC, Sudjaritruk T, Nallusamy R, Lumbiganon P, Rungmaitree S, Hansudewechakul R, Kumarasamy N, Bunupuradah T, Saphonn V, Truong KH, Yusoff NKN, Do VC, Nguyen LV, Razali KAM, Fong SM, Kurniati N, Kariminia A. Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia. J Adolesc Health. 2016 Apr; 58(4):451-459. PMID: 26803201; PMCID: PMC4808326 [Available on 04/01/17].
    17. Ahn JY, Boettiger D, Law M, Kumarasamy N, Yunihastuti E, Chaiwarith R, Lee MP, Sim BL, Oka S, Wong W, Kamarulzaman A, Kantipong P, Phanuphak P, Ng OT, Kiertiburanakul S, Zhang F, Pujari S, Ditangco R, Ratanasuwan W, Merati TP, Saphonn V, Sohn AH, Choi JY. Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression. J Acquir Immune Defic Syndr. 2015 Jul 01; 69(3):e85-92. PMID: 25850606; PMCID: PMC4506699.
    18. Boettiger DC, Kerr S, Ditangco R, Chaiwarith R, Li PC, Merati TP, Pham TT, Kiertiburanakul S, Kumarasamy N, Vonthanak S, Lee CK, Van Kinh N, Pujari S, Wong WW, Kamarulzaman A, Zhang F, Yunihastuti E, Choi JY, Oka S, Ng OT, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Law M. Tenofovir-based antiretroviral therapy in ?HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database. Antivir Ther. 2016; 21(1):27-35. PMID: 26069150; PMCID: PMC4757505 [Available on 01/01/17].
    19. Aurpibul L, Bunupuradah T, Sophan S, Boettiger D, Wati DK, Nguyen LV, Saphonn V, Hansudewechakul R, Chokephaibulkit K, Lumbiganon P, Truong KH, Do VC, Kumarasamy N, Yusoff NK, Razali K, Kurniati N, Fong SM, Nallusamy R, Sohn AH. Prevalence and incidence of liver dysfunction and assessment of biomarkers of liver disease in HIV-infected Asian children. Pediatr Infect Dis J. 2015 Jun; 34(6):e153-8. PMID: 25970117; PMCID: PMC4435819.
    20. Boettiger DC, Nguyen VK, Durier N, Bui HV, Heng Sim BL, Azwa I, Law M, Ruxrungtham K. Efficacy of second-line antiretroviral therapy among people living with HIV/AIDS in Asia: results from the TREAT Asia HIV observational database. J Acquir Immune Defic Syndr. 2015 Feb 01; 68(2):186-95. PMID: 25590271; PMCID: PMC4296907.
    21. Boettiger DC, Saphonn V, Lee MP, Phanuphak P, Pham TT, Heng Sim BL, Kumarasamy N, Van Nguyen K, Kantipong P, Kamarulzaman A, Chaiwarith R, Kiertiburanakul S, Law MG. A clinical prediction tool for targeted pre-antiretroviral therapy creatinine testing applied to the TREAT Asia HIV observational database cohort. J Acquir Immune Defic Syndr. 2014 Dec 01; 67(4):e131-3. PMID: 25197829; PMCID: PMC4213211.
    22. Boettiger DC, Kerr S, Ditangco R, Merati TP, Pham TT, Chaiwarith R, Kiertiburanakul S, Li CK, Kumarasamy N, Vonthanak S, Lee C, Van Kinh N, Pujari S, Wong WW, Kamarulzaman A, Zhang F, Yunihastuti E, Choi JY, Oka S, Ng OT, Kantipong P, Mustafa M, Ratanasuwan W, Sohn A, Law M. Trends in first-line antiretroviral therapy in Asia: results from the TREAT Asia HIV observational database. PLoS One. 2014; 9(9):e106525. PMID: 25184314; PMCID: PMC4153611.
    23. Kiertiburanakul S, Boettiger D, Lee MP, Omar SF, Tanuma J, Ng OT, Durier N, Phanuphak P, Ditangco R, Chaiwarith R, Kantipong P, Lee CK, Mustafa M, Saphonn V, Ratanasuwan W, Merati TP, Kumarasamy N, Wong WW, Zhang F, Pham TT, Pujari S, Choi JY, Yunihastuti E, Sungkanuparph S. Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients. J Int AIDS Soc. 2014; 17:18804. PMID: 24598459; PMCID: PMC3944639.
    24. Boettiger DC, Kiertiburanakul S, Sungkanuparph S, Law MG. The impact of wild-type reversion on transmitted resistance surveillance. Antivir Ther. 2014; 19(7):719-22. PMID: 24535375; PMCID: PMC4135036.
    David's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.